Baring Emerging Europe PLC
5 July 2004
Directorate Changes
Miss Josephine Dixon and Mr Saul Estrin have today been appointed as Directors
of Baring Emerging Europe PLC.
The company has been advised that Miss Dixon is also a director of the following
publicly quoted company:
Finsbury Worldwide Pharmaceutical Trust PLC.
Miss Dixon has not held any other directorships in publicly quoted companies
during the previous five years. There are no details to be disclosed for Miss
Dixon pursuant to paragraph 6.F.2(b) to (g) of the Listing Rules.
The Company has been advised that Professor Estrin is not a director of any
other publicly quoted companies and has not held any previous directorships of
such companies. There are no details to be disclosed for Professor Estrin
pursuant to paragraph 6.F.2(b) to (g) of the Listing Rules.
Enquiries:
Mike Nokes (Company Secretary) Tel No: 020 7762 8405
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.